You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Insulin degrading enzyme / IDE antibody [9B12.225] (ab25733)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab25733? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab25733 has been referenced in 6 publications.

  1. Kilger E et al. BRI2 Protein Regulates {beta}-Amyloid Degradation by Increasing Levels of Secreted Insulin-degrading Enzyme (IDE). J Biol Chem 286:37446-57 (2011). IP; Human. PubMed: 21873424
  2. Solas M et al. Interactions between age, stress and insulin on cognition: implications for Alzheimer's disease. Neuropsychopharmacology 35:1664-73 (2010). WB; Rat. PubMed: 20182419
  3. Du J et al. Metabolites of cerebellar neurons and hippocampal neurons play opposite roles in pathogenesis of Alzheimer's disease. PLoS One 4:e5530 (2009). WB. PubMed: 19436731
  4. Bernstein HG et al. Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary. J Chem Neuroanat 35:216-24 (2008). PubMed: 18226493
  5. Cook DG et al. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol 162:313-9 (2003). PubMed: 12507914
  6. Shii K & Roth RA Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease. Proc Natl Acad Sci U S A 83:4147-51 (1986). PubMed: 2424018

Publishing research using ab25733? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"